ABBV vs. CI: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ABBV and CI, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ABBV dominates in value with a market cap of 321.13 billion USD, eclipsing CI’s 84.71 billion USD by roughly 3.79×.
With betas of 0.55 for ABBV and 0.48 for CI, both show similar volatility profiles relative to the overall market.
| Symbol | ABBV | CI |
|---|---|---|
| Company Name | AbbVie Inc. | Cigna Corporation |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical - Healthcare Plans |
| CEO | Mr. Robert A. Michael CPA | Mr. David Michael Cordani |
| Price | 181.8 USD | 317.09 USD |
| Market Cap | 321.13 billion USD | 84.71 billion USD |
| Beta | 0.55 | 0.48 |
| Exchange | NYSE | NYSE |
| IPO Date | January 2, 2013 | March 31, 1982 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ABBV and CI over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between ABBV and CI, please refer to the table below.
| Symbol | ABBV | CI |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 76.62 | 17.66 |
| Forward PEG Ratio (TTM) | 7.16 | 1.52 |
| Price-to-Sales Ratio (P/S, TTM) | 5.60 | 0.33 |
| Price-to-Book Ratio (P/B, TTM) | 226.35 | 2.21 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 20.87 | 14.09 |
| EV-to-EBITDA (TTM) | 23.58 | 9.69 |
| EV-to-Sales (TTM) | 6.73 | 0.42 |
| EV-to-Free Cash Flow (TTM) | 25.08 | 17.77 |
Dividend Comparison
ABBV’s dividend yield of 3.51% is about 95% higher than CI’s 1.80%, underscoring its stronger focus on returning cash to shareholders.
| Symbol | ABBV | CI |
|---|---|---|
| Dividend Yield (TTM) | 3.51% | 1.80% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ABBV and CI, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- With current ratios of 0.76 and 0.78, both ABBV and CI have less current assets than short-term liabilities, which could strain their working capital and force reliance on additional financing.
- Both ABBV (quick ratio 0.64) and CI (quick ratio 0.69) fall below 0.8, meaning their most liquid assets—excluding inventory—aren’t enough to meet short-term obligations. This could force them to rely on receivables, inventory turn, or external financing.
- ABBV is heavily leveraged (debt-to-equity ratio 49.22), which can boost returns but raises risk if borrowing costs climb, while CI at 0.76 keeps leverage at a more moderate level.
| Symbol | ABBV | CI |
|---|---|---|
| Current Ratio (TTM) | 0.76 | 0.78 |
| Quick Ratio (TTM) | 0.64 | 0.69 |
| Debt-to-Equity Ratio (TTM) | 49.22 | 0.76 |
| Debt-to-Assets Ratio (TTM) | 0.51 | 0.20 |
| Interest Coverage Ratio (TTM) | 6.14 | 4.64 |